Biotherapies in Uveitis

Biotherapies in Uveitis

Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed countries. The therapeutic strategy aims to rapidly control intra-ocular inflammation, prevent irremediable ocular damage, allow corticosteroid sparing and save the vision, and has evolved over the last few y...

Full description

Bibliographic Details
Main Authors: Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, Georgina Maalouf, Sara Touhami, Patrice Cacoub, Bahram Bodaghi, David Saadoun
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
non-infectious uveitis
biotherapy
anti-TNF-α (anti-tumor necrosis factor alpha) agent
tocilizumab
Janus Associated Kinase (JAK) inhibitors
Online Access:https://www.mdpi.com/2077-0383/9/11/3599

Internet

https://www.mdpi.com/2077-0383/9/11/3599

Similar Items